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Emanuel EJ, Wendler D, Grady C. What makes 
clinical research ethical? JAMA. 2000 May 24-
31;283(20):2701-11. 
 What makes research involving human 
subjects ethical? 
 Informed consent is necessary (in most cases) but not 
sufficient 
 Other issues: clinical research in developing 
countries, use of placebos, phase 1 research, 
protection for communities, involvement of children 
 A systematic framework is proposed to 
evaluate clinical studies 
1. Social or Scientific Value 
2. Scientific Validity 
3. Fair Subject Selection 
4. Favorable Risk-Benefit Ratio 
5. Independent Review 
6. Informed Consent 
7. Respect for Potential and Enrolled Subjects 
 To be valuable, research should 
 evaluate an intervention that could lead to 
improvements in health or well-being 
 be a preliminary study to such research 
 Lead to general knowledge about structure/function 
of human biological systems 
 Why? 
 Responsible use of finite resources 
 Avoidance of exploitation 
 Consider comparing the relative value of 
different clinical research studies 
 
 “Scientifically unsound research on human subjects is 
ipso facto unethical in that it may expose subjects to 
risks or inconvenience to no purpose.” 
 International Ethical Guidelines for Biomedical Research involving 
Human Subjects – CIOMS, 1993.  
 Research should have a clear scientific objective, be 
designed using accepted principles, methods and 
reliable practices, have sufficient power, offer plausible 
data analysis plan  
 Must have honest null hypothesis, “clinical equipoise” 
 Why? 
 Responsible use of finite resources 
 Avoidance of exploitation 
 Scientific goals of the study should be primary 
basis for determining who will be enrolled 
 Groups should not be excluded without good reason 
 Recognize that subject selection can affect the 
risks and benefits of the study 
 Groups/individuals who bear the risks of 
research should be able to enjoy its benefits 
 Why? 
 Equals should be treated similarly, benefits/burdens 
should be distributed evenly 
 
 Assessment of potential risks 
 Risks to individual subjects are identified and minimized 
 Procedures which are consistent with sound research design 
 Using procedures already being performed on the subjects 
for diagnostic/treatment purposes 
 Potential benefits to individual subjects are enhanced 
 Should be consistent with the scientific objectives, tests and 
interventions 
 Extraneous benefits (e.g. payment, more unrelated health 
services) should not be weighed against the risks 
 Risks and benefits to individual subjects are compared  
 The more likely/serious the potential risks are, the greater 
the prospective benefits should be 
 What if no clinical benefit to subjects (e.g. Phase I 
trial)? 
 “risk-knowledge calculus”*: when do benefits to society 
outweigh risks to individuals 
 No stable framework 
 Utilitarian approach controversial 
 *Weijer C. Thinking clearly about research risk: implications of the work of Benjamin 
Freedman. IRB. 1999 Nov-Dec;21(6):1-5. 
 Why? 
 Beneficence 
 Need to enhance benefits 
 Need to avoid the exploitation of subjects 
 Nonmaleficence 




 Minimize the potential impacts of conflicts of 
interest (e.g. to conduct high-quality research, 
complete the research expeditiously, protect 
research subjects, obtain funding, advance 
career) 
 Social accountability  
 Who? 
 Granting agencies 
 Local IRBs 
 Data and safety monitoring board 
 Purpose: 
 To ensure that individuals control whether or not they 
participate 
 To ensure that individuals participate only when research 
is consistent with values/interests/preferences.  
 To provide informed consent: 
 Must be accurately informed of details 
 Understand this information and how it relates to their 
situation 
 Make a voluntary and uncoerced decision about whether 
to participate 
 Non-autonomous persons should be respected 
 Substituted judgement 
 Best interests 
 Respect privacy by managing information in 
accordance with confidentiality rules 
 Subjects should be permitted to change their 
mind and withdraw without penalty 
 Enrolled subjects should be provided with new 
information regarding the intervention should 
it become available 
 Welfare of subjects should be monitored.  
 Study subjects should be informed about what 
was learned from the research 
1. Social or Scientific Value 
2. Scientific Validity 
3. Fair Subject Selection 
4. Favorable Risk-Benefit Ratio 
5. Independent Review 
6. Informed Consent 
7. Respect for Potential and Enrolled Subjects 
 
